Programs around the country already do this, so it’s plausible that Neuralink could one day achieve the same, experts said. However, scientists’ grasp on exactly how the technology works is still evolving. “We just have the understanding of bits and pieces,” said Rachel Davis, director of OCD and neuromodulation programs at the University of Colorado Anschutz Medical Campus, which is working on the technology.